StockWatch
·
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Business UpdateAug 12, 2026, 04:09 PM

Q/C Technologies Terminates LightSolver Deal, Impairs License

AI Summary

Q/C Technologies, Inc. announced the termination of its exclusive global licensing agreement with LightSolver Ltd., leading to a significant impairment of its technology license by over $3.1 million. This strategic shift means the company will now fully focus on its proprietary optical processing unit initiative for AI inference and quantum/laser-based computer technology. The company reported a net loss of $(7.86) million for the first six months of 2026, an increase from the prior year, and remains pre-revenue.

Key Highlights

  • Terminated License Agreement with LightSolver Ltd. on June 26, 2026.
  • Impaired Technology License by $3,177,999 for the six months ended June 30, 2026.
  • Reported a net loss of $(7,859,013) for the six months ended June 30, 2026, up from $(2,920,938) in 2025.
  • Total assets decreased to $22,865,754 as of June 30, 2026, from $41,166,096 at December 31, 2025.
  • Total liabilities decreased to $3,791,478 as of June 30, 2026, from $16,441,042 at December 31, 2025.
  • Shifted focus to optical processing unit initiative and quantum/laser-based computer technology.
  • Cash and cash equivalents decreased to $307,612 as of June 30, 2026, from $986,996 at December 31, 2025.
  • Stock-based compensation expenses significantly increased to $2,432,261 for the six months ended June 30, 2026.